📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

SLC6A2 genotype variation and the modulatory effects of atomoxetine on inhibitory control in individuals with and without cocaine use disorder (2017)

First Author: Le A

Attributed to: Atomoxetine as a pharmacological treatment for chronic cocaine and heroin abusers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0924-977x(17)31865-5

Publication URI: http://dx.doi.org/10.1016/s0924-977x(17)31865-5

Type: Journal Article/Review

Parent Publication: European Neuropsychopharmacology